Because our EC data and previous studies have demonstrated that IL-1α and IL-1β contribute to vascular inflammation/atherogenesis [13–15], the elevated activity of IL-1 in psoriasis may contribute to this increased risk of atherosclerosis. This evidence concerns the gene IL1B and atherosclerosis.